机构:[1]Barcelona Univ, Hosp Clin, Hematol Oncol Dept, Div Med Oncol, Barcelona, Spain;[2]Curie Manavata Canc Ctr, Nasik, India;[3]NH Hosp AS, Nemocnice Horovice, Prague, Czech Republic;[4]Sotira Gen Hosp, Athens Sch Med, Athens, Greece;[5]PUCRS Pontificia Univ Rio Grande Sul, Porto Alegre, RS, Brazil;[6]Ctr Med Colima, Colima, Mexico;[7]Sun Yat Sen Univ, Ctr Canc, East Guangzhou, Peoples R China;中山大学肿瘤防治中心[8]Univ Penn, Philadelphia, PA 19104 USA;[9]Amgen Inc, Thousand Oaks, CA 91320 USA
出处:
ISSN:
基金:
Amgen Inc.Amgen
语种:
外文
WOS:
中科院(CAS)分区:
出版当年[2017]版:
大类|1 区医学
小类|1 区肿瘤学
最新[2023]版:
大类|1 区医学
小类|1 区肿瘤学
第一作者:
第一作者机构:[1]Barcelona Univ, Hosp Clin, Hematol Oncol Dept, Div Med Oncol, Barcelona, Spain;
推荐引用方式(GB/T 7714):
Gascon P.,Nagarkar R.,Smakal M.,et al.Long-term safety and efficacy of darbepoetin alfa in subjects with stage IV NSCLC receiving multi-cycle chemotherapy[J].ANNALS OF ONCOLOGY.2017,28:-.
APA:
Gascon, P.,Nagarkar, R.,Smakal, M.,Syrigos, K.,Barrios, C. H....&Brandao, C. De Oliveira.(2017).Long-term safety and efficacy of darbepoetin alfa in subjects with stage IV NSCLC receiving multi-cycle chemotherapy.ANNALS OF ONCOLOGY,28,
MLA:
Gascon, P.,et al."Long-term safety and efficacy of darbepoetin alfa in subjects with stage IV NSCLC receiving multi-cycle chemotherapy".ANNALS OF ONCOLOGY 28.(2017):-